Zhang Jing, Chen Siyu, Zheng Haiying, Rao Siyi, Lin Yuanyuan, Wan Jianxin, Chen Yi
Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China.
PeerJ. 2024 Dec 9;12:e18703. doi: 10.7717/peerj.18703. eCollection 2024.
In recent years, ectopic lymphoid tissue (ELT) has been increasingly confirmed as a new biomarker for kidney injury or inflammation. However, there is insufficient research on the relationship between ELT grading and the progression of idiopathic membranous nephropathy (IMN).
A total of 147 patients with biopsy-proven IMN in our institution from March 2020 to June 2022 were classified into five grades based on the different distribution of lymphocyte subsets in renal tissue (G0: no B cells or T cells, G1: scattered B and T cells, G2: clustered B and T cells, G3: an aggregation region of B and T cells without a central network, G4: highly organized and formed zones of B and T cells with a central network of follicular dendritic cells and scattered macrophages), and were further divided into low-grade group (G0+G1), intermediate-grade group (G2) and high-grade group (G3+G4). The clinicopathological data, induction treatment response and prognosis among the three groups were analyzed and compared retrospectively.
As the grading of ectopic lymphoid tissues increased, patients were older, with a higher prevalence of hypertension, a higher 24-h urinary protein level, lower baseline hemoglobin and estimated glomerular filtration rate (eGFR) levels, and more severe renal pathological damage. Logistic regression analysis showed that after 6 months of induction treatment, patients in the high-grade group were more likely to be in non-remission than those in the low-grade group (odds ratios [ORs] of the three adjusted models were 4.310, 4.239, and 5.088, respectively, -values were 0.005, 0.006, and 0.001, respectively). Kaplan-Meier survival analysis indicated that patients in the intermediate- and high-grade groups had significantly lower renal cumulative survival rate than those in the low-grade group ( = 0.025). Univariate Cox analysis showed that the risk of adverse renal outcome was 3.662 times higher in the intermediate- and high-grade groups than in the low-grade group (95% confidence interval [CI] [1.078-12.435]; = 0.037). Multivariate Cox analysis revealed that failure of remission at the first 6 months (hazard ratio [HR] = 5.769; 95% CI [1.854-17.950]; = 0.002) remained an independent risk factor for poor renal outcome in patients with IMN.
Grading of renal ectopic lymphoid tissues correlates with disease activity and severity in IMN patients and can be used as an indicator to assess the risk of IMN progression.
近年来,异位淋巴组织(ELT)已越来越多地被确认为肾脏损伤或炎症的一种新生物标志物。然而,关于ELT分级与特发性膜性肾病(IMN)进展之间的关系,研究尚不充分。
2020年3月至2022年6月期间,我院共147例经活检证实为IMN的患者,根据肾组织中淋巴细胞亚群的不同分布分为五个等级(G0:无B细胞或T细胞;G1:散在的B细胞和T细胞;G2:聚集的B细胞和T细胞;G3:B细胞和T细胞的聚集区域,无中央网络;G4:高度组织化,形成B细胞和T细胞区域,有滤泡树突状细胞中央网络和散在巨噬细胞),并进一步分为低级别组(G0+G1)、中级别组(G2)和高级别组(G3+G4)。回顾性分析比较三组患者的临床病理资料、诱导治疗反应及预后情况。
随着异位淋巴组织分级增加,患者年龄更大,高血压患病率更高,24小时尿蛋白水平更高,基线血红蛋白和估计肾小球滤过率(eGFR)水平更低,肾脏病理损伤更严重。Logistic回归分析显示,诱导治疗6个月后,高级别组患者未缓解的可能性高于低级别组(三个校正模型的比值比[OR]分别为4.310、4.239和5.088,P值分别为0.005、0.006和0.001)。Kaplan-Meier生存分析表明,中级别组和高级别组患者的肾脏累积生存率显著低于低级别组(P=0.025)。单因素Cox分析显示,中级别组和高级别组发生不良肾脏结局的风险比低级别组高3.662倍(95%置信区间[CI][1.078-12.435];P=0.037)。多因素Cox分析显示,最初6个月未缓解(风险比[HR]=5.769;95%CI[1.854-17.950];P=0.002)仍是IMN患者发生不良肾脏结局的独立危险因素。
肾异位淋巴组织分级与IMN患者的疾病活动度和严重程度相关,可作为评估IMN进展风险的指标。